Literature DB >> 32613841

Leukocyte telomere length: a potential biomarker for the prognosis of coronary artery disease.

Ying Sun1, Wei Wang1, Yue-Ru Jiao1, Jian Ren2, Lei Gao3, Yang Li3, Ping Hu3, Tian-Ying Ren3, Qian-Feng Han1, Chen Chen4, Heng-Chen Yao1.   

Abstract

Aim: This study aimed to explore the prognostic value of leukocyte telomere length (LTL) in patients with coronary artery disease (CAD). Materials & methods: We enrolled 366 CAD patients and 76 healthy subjects in this study. LTL was measured. All subjects were followed up for 6 months for further analysis regarding major adverse cardiac events (MACEs).
Results: CAD patients had a significantly shortened LTL compared with healthy subjects (p < 0.05). The area under the curve for LTL prediction of MACEs was 0.769 (p < 0.001), with a shorter LTL being an independent predictor of MACEs (Cox proportional hazards regression, hazard ratio: 2.866; p < 0.001).
Conclusion: LTL could be considered as an independent predictor of short-term MACEs in CAD.

Entities:  

Keywords:  biomarker; coronary artery disease; leukocyte telomere length; prognosis

Year:  2020        PMID: 32613841     DOI: 10.2217/bmm-2020-0171

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  1 in total

Review 1.  Leukocyte Telomere Length as a Molecular Biomarker of Coronary Heart Disease.

Authors:  Olga V Zimnitskaya; Marina M Petrova; Natalia V Lareva; Marina S Cherniaeva; Mustafa Al-Zamil; Anastasia E Ivanova; Natalia A Shnayder
Journal:  Genes (Basel)       Date:  2022-07-12       Impact factor: 4.141

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.